Agency classClass IIOur severity:Severe FDA (Drugs)·D-0005-2027·Announced 2026-10-14

K.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns

K.C. Pharmaceuticals is recalling multiple brands of eye drops due to a lack of assurance of sterility. The recall covers 1,435,830 cartons distributed nationwide.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which indicates a reasonable probability of serious adverse health consequences or death, specifically due to a lack of assurance of sterility. The source does not report any illnesses, injuries, or deaths.

Plain-English summary

K.C. Pharmaceuticals, Inc. is recalling 1,435,830 cartons of eye drops containing glycerin and naphazoline hydrochloride. The recall is being conducted because of a lack of assurance of sterility in the product. The affected products are sold under various brand names, including Target Eye Drops Maximum Redness Relief Eye, Harris Teeter, Tyson, up & up, TopCare Health, and Walgreens.

The recall covers specific lot numbers with expiration dates ranging from January 2027 to October 2027. The products were distributed nationwide. The source text does not report any illnesses, injuries, or deaths associated with this recall.

Consumers should stop using the recalled eye drops and check their lot numbers and expiration dates against the list provided in the official recall notice. Those with questions should contact the recalling firm or their healthcare provider.

The recalled product

Product: TARGET EYE DROPS MAXIMUM REDNESS RELIEF EYE (GLYCERIN, NAPHAZOLINE HYDROCHLORIDE)
Brand: TARGET EYE DROPS MAXIMUM REDNESS RELIEF EYE
Manufacturer: K.C. Pharmaceuticals, Inc.
Category: Drug — Ophthalmic
Hazard: sterility
Affected units: 1,435,830

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

Lot: a) CM25E02
Exp.: 5/31/2027
CM25M01
Exp.: 10/31/2027
b) CM25E02
c) CM25C01
Exp.: 3/31/2027
CM25C02
CM25C03
CM25E02
CM25F01
Exp.: 6/30/2027
CM25A02
Exp.: 1/1/2027
CM25B01
Exp.: 2/28/2027
d) CM25B01
CM25E01
CM25K01
Exp.: 9/30/2027

UPCs (5)

614299896369
072036735898
784847575494
036800211230
311917200750

Distribution

Distributed nationwide across the United States.

Same manufacturer · K.C. Pharmaceuticals, Inc.

See all →

Severe
K.C. Pharmaceuticals Recalls Leader Ultra Lubricating Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Severe
K.C. Pharmaceuticals Recalls Good Sense Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Severe
K.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Severe
K.C. Pharmaceuticals Recalls Artificial Tears Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
Severe
Good Sense Eye Drops Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-10-14

Same hazard · sterility